Similar Papers

Paper Title
Journal
Date
Author
Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors and adverse cardiovascular events: a population-based study
S Lee ... G Tse
European Heart Journal | VOL. 43
S Lee, et. al.S Lee ... G Tse
04 Feb 2022
Efficacy and safety comparison of PD-1 inhibitors vs. PD-L1 inhibitors in extensive-stage small-cell lung cancer: a retrospective comparative cohort study.
Guanghui Yang ... Wei Huang
Journal of Thoracic Disease | VOL. 14
Guanghui Yang, et. al.Guanghui Yang ... Wei Huang
01 Dec 2022
Immunotherapy efficacy and safety of programmed cell death 1 (PD-1) versus programmed death ligand-1 (PD-L1) inhibitors in pan-cancer: A systematic review and meta-analysis.
Jianchun Duan ... Jia Song
Journal of Clinical Oncology | VOL. 37
Jianchun Duan, et. al.Jianchun Duan ... Jia Song
20 May 2019
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity.
Jay Shah ... Yinghong Wang
American journal of clinical oncology | VOL. -
Jay Shah, et. al.Jay Shah ... Yinghong Wang
30 Oct 2024
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Arginase-1-specific T cells target and modulate tumor-associated macrophages
Evelina Martinenaite ... Mads Hald Andersen
Journal for ImmunoTherapy of Cancer | VOL. 13
Evelina Martinenaite, et. al.Evelina Martinenaite ... Mads Hald Andersen
29 Jan 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
Binod Dhakal ... Daniel H Fowler
Journal for ImmunoTherapy of Cancer | VOL. 13
Binod Dhakal, et. al.Binod Dhakal ... Daniel H Fowler
28 Jan 2025
Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity
Yusuke Ito ... Yuki Kagoya
Journal for ImmunoTherapy of Cancer | VOL. 13
Yusuke Ito, et. al.Yusuke Ito ... Yuki Kagoya
26 Jan 2025
B7-H3 CAR-T cell therapy combined with irradiation is effective in targeting bulk and radiation-resistant chordoma cancer cells
Kun Wang ... Joseph H Schwab
Journal for ImmunoTherapy of Cancer | VOL. 13
Kun Wang, et. al.Kun Wang ... Joseph H Schwab
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.